{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:33:34Z","timestamp":1786739614722,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To provide real-world data on the world-wide-web for patient and doctor awareness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>From December 2017 to January 2020, consecutive patients with choroidal melanoma (CM), iris ciliary body melanoma (ICM), and ocular surface squamous carcinoma (OSSC) had specific outcomes recorded at each return visit. Each result was anonymized, entered in an online portal, and sent to a unique software program where it was used to create real-world data of number of patients, mean vision, local tumor control, eye salvage, systemic metastases, and length of follow-up for our eye cancer center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A HIPAA compliant, internet-based software program was developed and linked to public access web page to collect and analyze near-real-time data pertaining to the treatment, vision, life, and follow-up time of patients. During this period, CM radiation plaque tumor control was 99.7%, median vision 20\/25 (mean 20\/50) and eye salvage 95.8%. ICM tumor control was 99.1% and the median vision 20\/20 (mean 20\/20). OSSC tumor control was 100% and the most common vision was 20\/20 (mean 20\/25). Rates of primary enucleation as treatment were 4.2% for CM, 2.8% for ICM, and 0% for OSSC. All patient results were updated by the ophthalmic oncology fellow at each patient visit as to reflect near-real-time outcomes at our center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Prospective data collection of returning patients was found to be a simple method to reflect patient care outcomes. This method of reporting doctor outcomes offers a measure of transparency for patients and an opportunity to compare results with other clinical practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_257_20","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T08:27:00Z","timestamp":1608020820000},"page":"135-139","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Doctor reported outcomes"],"prefix":"10.4103","volume":"69","author":[{"given":"Abhilasha","family":"Maheshwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Malpani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit Singh","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-39-20240828","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41571-019-0167-7","article-title":"Real-world data: Towards achieving the achievable in cancer care","volume":"16","author":"Booth","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"R3-39-20240828","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMp1614720","article-title":"From trial to target populations - calibrating real-world data","volume":"376","author":"Najafzadeh","year":"2017","journal-title":"N Engl J Med"},{"key":"R4-39-20240828","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clinthera.2018.12.013","article-title":"The case for real-world evidence in the future of clinical research on chronic myeloid leukemia","volume":"41","author":"Webster","year":"2019","journal-title":"Clin Ther"},{"key":"R8-39-20240828","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-13-38","article-title":"e-Monitoring of asthma therapy to improve compliance in children using a real-time medication monitoring system (RTMM): The e-MATIC study protocol","volume":"13","author":"Vasbinder","year":"2013","journal-title":"BMC Med Inform Decis Mak"},{"key":"R9-39-20240828","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cct.2015.03.012","article-title":"Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationale","volume":"42","author":"Blake","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"R10-39-20240828","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/end.2014.0643","article-title":"Internet-based patient survey on urolithiasis treatment and patient satisfaction","volume":"29","author":"Chandrasekar","year":"2015","journal-title":"J Endourol"},{"key":"R11-39-20240828","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.2196\/jmir.2319","article-title":"An evaluation of web-based clinical practice guidelines for managing problems associated with cannabis use","volume":"14","author":"Norberg","year":"2012","journal-title":"J Med Internet Res"},{"key":"R12-39-20240828","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jamaophthalmol.2019.3116","article-title":"Assessment of the quality, content, and readability of freely available online information for patients regarding diabetic retinopathy","volume":"137","author":"Kloosterboer","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"R13-39-20240828","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1109\/JBHI.2017.2782210","article-title":"Improving health outcomes sooner rather than later via an interactive website and virtual specialist","volume":"22","author":"Richards","year":"2018","journal-title":"IEEE J Biomed Health Inform"},{"key":"R14-39-20240828","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1001\/jama.288.23.3027","article-title":"Health-related quality-of-life assessments and patient-physician communication: A randomized controlled trial","volume":"288","author":"Detmar","year":"2002","journal-title":"JAMA"},{"key":"R15-39-20240828","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/rheumatology\/kes285","article-title":"Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: The DUO study","volume":"52","author":"Dougados","year":"2013","journal-title":"Rheumatology (Oxford"},{"key":"R16-39-20240828","first-page":"61","article-title":"Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Health Serv Insights"},{"key":"R17-39-20240828","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMp1611252","article-title":"Patient-Reported Outcomes - Harnessing Patients' Voices to Improve Clinical Care","volume":"376","author":"Basch","year":"2017","journal-title":"N Engl J Med"},{"key":"R18-39-20240828","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp1702978","article-title":"Patient-reported outcomes - Are they living up to their potential?","volume":"377","author":"Baumhauer","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_257_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:30:32Z","timestamp":1786735832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_257_20"}},"subtitle":["Real-world data from a tertiary eye cancer center"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_257_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}